Literature DB >> 9146610

Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers.

D K Ornstein1, D S Smith, G S Rao, J W Basler, T L Ratliff, W J Catalona.   

Abstract

PURPOSE: We determined the biological variation of the total, free and percent free serum prostate specific antigen (PSA) in men 50 years old or older.
MATERIALS AND METHODS: Between July 1995 and February 1996 we studied 84 healthy men from our PSA screening study to determine biological variation by calculating the coefficients of variation of 3 PSA measurements on blood samples drawn from each subject 2 weeks apart.
RESULTS: The mean coefficients of variation for total, free and percent free serum PSA were 15, 17 and 14%, respectively. Age, total PSA and ejaculation were not confounding factors in this analysis (that is multivariate R2 less than 5% for all indexes).
CONCLUSIONS: There is a mean variation of approximately 15% in measurements of total, free and percent free PSA that does not appear to be significantly affected by age and total PSA level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9146610

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Brief report: Free prostate-specific antigen test utilization. Consistency with guidelines.

Authors:  Brian R Jackson; William L Roberts
Journal:  J Gen Intern Med       Date:  2005-09       Impact factor: 5.128

2.  Molecular staging by RT-pCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer.

Authors:  Constantine S Mitsiades; Peter Lembessis; Antigone Sourla; Constantine Milathianakis; Athanassios Tsintavis; Michael Koutsilieris
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels.

Authors:  R M Hoffman; D L Clanon; B Littenberg; J J Frank; J C Peirce
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

4.  Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.

Authors:  Anders Christensson; Laila Bruun; Thomas Björk; Angel M Cronin; Andrew J Vickers; Caroline J Savage; Hans Lilja
Journal:  BJU Int       Date:  2010-10-18       Impact factor: 5.588

5.  Variation in serum prostate-specific antigen levels in men with prostate cancer managed with active surveillance.

Authors:  Behfar Ehdaie; Bing Ying Poon; Daniel D Sjoberg; Pedro Recabal; Vincent Laudone; Karim Touijer; James Eastham; Peter T Scardino
Journal:  BJU Int       Date:  2015-10-26       Impact factor: 5.588

6.  Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer.

Authors:  Donna Pauler Ankerst; Jonathan Gelfond; Martin Goros; Jesus Herrera; Andreas Strobl; Ian M Thompson; Javier Hernandez; Robin J Leach
Journal:  J Urol       Date:  2016-03-12       Impact factor: 7.450

7.  Adding free to total prostate-specific antigen levels in trials of prostate cancer screening.

Authors:  N J Wald; H C Watt; L George; P Knekt; K J Helzlsouer; J Tuomilehto
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.